Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
Jason Butler Reiterated (AQST) at Buy and Held Target at $9 on, Aug 12th, 2024
Jason Butler of JMP Securities, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $9 on, Aug 12th, 2024.
Jason has made no other calls on AQST in the last 4 months.
There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $9 on, Friday, July 26th, 2024
- Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $8 on, Friday, May 10th, 2024
Contributing Sources